HRT Financial’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-47,168
Closed -$1.27M 3570
2025
Q1
$1.27M Buy
+47,168
New +$1.49M 0.01% 1015
2024
Q2
Sell
-6,119
Closed -$296K 3158
2024
Q1
$296K Sell
6,119
-3,395
-36% -$166K ﹤0.01% 1563
2023
Q4
$509K Buy
+9,514
New +$481K ﹤0.01% 1357
2023
Q3
Sell
-3,660
Closed -$230K 3138
2023
Q2
$230K Sell
3,660
-3,169
-46% -$202K ﹤0.01% 1772
2023
Q1
$429K Buy
+6,829
New +$407K 0.01% 1488
2022
Q3
Sell
-18,723
Closed -$1.35M 3536
2022
Q2
$1.35M Buy
+18,723
New +$1.39M 0.01% 748
2022
Q1
Sell
-8,475
Closed -$857K 3914
2021
Q4
$857K Buy
+8,475
New +$845K ﹤0.01% 1262
2021
Q3
Sell
-11,397
Closed -$1.17M 3781
2021
Q2
$1.17M Buy
+11,397
New +$1.14M 0.01% 921
2021
Q1
Sell
-3,592
Closed -$276K 3173
2020
Q4
$276K Sell
3,592
-2,760
-43% -$213K 0.01% 1342
2020
Q3
$467K Sell
6,352
-140
-2% -$11.2K 0.01% 909
2020
Q2
$476K Buy
+6,492
New +$509K 0.01% 796
2020
Q1
Sell
-3,284
Closed -$257K 1381
2019
Q4
$257K Buy
+3,284
New +$242K 0.01% 822
2019
Q1
Sell
-1,824
Closed -$214K 803
2018
Q4
$214K Buy
+1,824
New +$211K 0.03% 461

Other funds holding USNA

HRT Financial's USNA Position: Q2 2025 in Review

HRT Financial sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 47,168 shares — an estimated $1.27M sold.

HRT Financial first reported a position in USNA in Q4 2018 and held it in 13 quarters. The position peaked at $1.35M in Q2 2022. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • HRT Financial reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 47,168 Usana Health Sciences shares in Q2 2025, an estimated $1.27M.
  • HRT Financial first reported a position in Usana Health Sciences in Q4 2018 and held it in 13 quarters.
  • HRT Financial's Usana Health Sciences position peaked at $1.35M in Q2 2022.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.